In a children's hospital in Los Angeles, two physicians have spent the past year offering a newer kind of answer to an old and quiet difficulty: teenagers with Down syndrome whose sleep apnea has resisted both surgery and the nighttime mask. Half to four-fifths of children with this condition struggle to breathe through their sleep, and the ordinary remedies do not reach everyone. Here a small implanted device, which gently awakens the tongue's nerve to hold the airway open, has become a considered option for those for whom the familiar paths have closed. Its promise is real, though the story
Inspire Nerve Stimulation Offers Sleep Apnea Option for Teens with Down Syndrome Who Can't Use Standard Treatments
Neither surgery nor a CPAP machine provides a workable solution
Mark
Why does this matter for teens with Down syndrome specifically?
Mimi
Because sleep apnea is so common in them, between 50% and 80% according to Dr. Ward, and the usual fixes often fall short.
Mark
What falls short about them?
Mimi
Tonsil and adenoid surgery helps some children but not all, and roughly half of people with Down syndrome struggle to tolerate a CPAP mask or use it consistently.
Mark
So how does Inspire get around that?
Mimi
It stimulates the nerve that moves the tongue, pulling it forward and opening the palate during sleep. A parent switches it on at bedtime with a remote.
Luke
Let me flag what we actually have. The 50% to 70% reduction in breathing events is Dr. Ward's figure, stated by a clinician offering the treatment.
Mimi
Fair. And Dr. Don's line that the kids have had very positive experiences is likewise her own characterization.
Luke
Right, and we aren't told how many patients have been implanted since July 2025, or how they're doing years out.
Mark
Is there anything the article does settle?
Mimi
The eligibility criteria, FDA approval, the three-hour surgery, the six-week wait before activation, and the battery life of 10 to 11 years are all stated plainly.
Luke
Those are specifics. Outcomes beyond that remain unknown from this piece.
Il Polso
- Roughly half of people with Down syndrome struggle with the CPAP mask, and surgery often fails to clear the airway, leaving families with few options.
- Children's Hospital Los Angeles has been implanting the Inspire nerve stimulator since July 2025, requiring a three-hour surgery and a careful set of eligibility checks.
- The device is switched on six weeks after surgery, then tuned through sleep studies so the stimulation ramps gently and the teen can pause it at night.
- Clinicians report breathing events falling by 50% to 70%, yet long-term outcome data has not yet been published, so the path ahead remains open.
In a children's hospital in Los Angeles, two physicians have spent the past year offering a newer kind of answer to an old and quiet difficulty: teenagers with Down syndrome whose sleep apnea has resisted both surgery and the nighttime mask. Half to four-fifths of children with this condition struggle to breathe through their sleep, and the ordinary remedies do not reach everyone. Here a small implanted device, which gently awakens the tongue's nerve to hold the airway open, has become a considered option for those for whom the familiar paths have closed. Its promise is real, though the story that has only just begun is still waiting for the years that will show whether its benefits endure.
At Children's Hospital Los Angeles, two physicians, otolaryngologist Debra Don and pulmonologist Sally Ward, have worked together since July 2025 to offer the Inspire hypoglossal nerve stimulation device to teenagers with Down syndrome. Their patients are those whose obstructive sleep apnea has not improved after removing adenoid and tonsil tissue and who cannot tolerate or consistently use a CPAP machine. Dr. Ward notes that between 50% and 80% of children with Down syndrome have sleep apnea, driven by a smaller airway, lower muscle tone and a larger tongue. Untreated, it can bring fatigue, trouble concentrating and behavioral difficulties, and over time raise the risk of stroke, heart disease and dementia.
To be eligible, a teen must be at least 13, meet weight requirements, have failed adenotonsillectomy, be unable to use CPAP, and tolerate the sleep endoscopy and sleep studies the process requires. The implant takes about three hours. A small generator sits in the chest and a cuff-shaped electrode wraps the hypoglossal nerve in the neck. Most patients go home the next day, and the device is activated six weeks later. At night, a remote lets the family start and stop it. The device senses breathing and gently moves the tongue forward so the airway stays open, with a signal mild enough not to wake the sleeper. Stimulation can ramp up over 20 minutes, can be paused for 15 minutes for a bathroom trip, and shuts off after 10 hours. The battery lasts 10 to 11 years.
Dr. Ward says the device can reduce breathing-related events by 50% to 70%, and Dr. Don reports that the children who have received it have had very positive experiences. The article does not offer long-term outcome data or patient numbers. Both doctors stress that the treatment requires close coordination between their two specialties and work with the manufacturer. The team welcomes referrals for any patient with Down syndrome, which Dr. Ward calls one of their passions.
At Children's Hospital Los Angeles, two physicians have spent more than a year offering a particular answer to a particular problem: teenagers with Down syndrome whose obstructive sleep apnea has not been solved by surgery or by a CPAP machine. Since July 2025, otolaryngologist Debra Don and pulmonologist Sally Ward have worked together to implant the Inspire hypoglossal nerve stimulation device in eligible adolescents.
The need is large. Dr. Ward says between 50% and 80% of children with Down syndrome have sleep apnea. Several anatomical factors raise the risk: a smaller airway, decreased muscle tone, and a larger tongue that can block the airway during sleep. Left untreated, the condition can contribute to fatigue, trouble concentrating and behavioral challenges, and over the long term to stroke, heart disease and dementia. Dr. Don says families should understand those risks, and Dr. Ward says reducing the severity of the condition can dramatically improve quality of life.
The standard options do not work for everyone. Removing adenoid and tonsillar tissue helps some children but not all. A CPAP machine can support breathing at night, yet roughly half of people with Down syndrome have trouble tolerating the mask or using it consistently.
The Inspire device is FDA-approved for adolescents with Down syndrome who meet several criteria. They must be 13 or older, meet the weight requirements for implantation, have seen no improvement after adenotonsillectomy, be unable to tolerate CPAP, and be able to tolerate the sleep endoscopy and sleep studies the treatment requires.
Implantation takes a three-hour surgery. Dr. Don describes a small battery, or generator, placed in the chest, and a small cuff-shaped electrode placed in the neck around the hypoglossal nerve, which moves the tongue. The electrode is connected to the generator. Patients can usually go home the next day, and the device is switched on for the first time six weeks later.
Parents receive a remote to turn the device on at bedtime and off in the morning. During sleep, the device senses the teen's breathing and signals the nerve, moving the tongue forward and opening the palate so the airway stays clear. The signal is mild enough not to wake the sleeper. The team uses sleep studies after implantation to find the right stimulation level. Dr. Ward says the stimulation can be set to ramp up gradually over the first 20 minutes of sleep so a teen can get used to the sensation, and it can be paused for 15 minutes if the teen needs to get up at night. The device shuts itself off after 10 hours of use, so it is not left running during the day. Its battery lasts 10 to 11 years, and replacing it requires a simple surgery with one small incision.
Dr. Ward says the device can reduce breathing-related events during sleep by 50% to 70%. Dr. Don says the children who have received it have had very positive experiences. The article offers no long-term outcome data or patient numbers.
For clinicians weighing the treatment, both doctors stress collaboration. Dr. Ward says it demands considerable coordination between pulmonology and otolaryngology, and that the team works closely with the manufacturer to answer families' technical questions. The team accepts referrals for sleep apnea evaluations. Dr. Ward says they are happy to see any patient with Down syndrome at any point, calling it one of their passions.
Citazioni salienti
Reducing the severity of this condition can dramatically improve quality of life.— Dr. Sally Ward, pulmonologist, Children's Hospital Los Angeles
The kids for whom we've implanted the device have had very positive experiences.— Dr. Debra Don, otolaryngologist, Children's Hospital Los Angeles
Vuoi la storia completa?
Leggi l'originale su News-Medical ↗
Health & Medicine